共 50 条
- [3] Safety Profile Based on Concordance of Nonclinical Toxicity and Clinical Adverse Drug Reactions for Blood Cancer Drugs Approved in Japan [J]. Drugs in R&D, 2017, 17 : 133 - 143
- [6] Postmarket safety communications on drugs approved in Japan: A 25-year analysis [J]. CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2024, 17 (04):
- [8] Safety of newly approved drugs questioned [J]. AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 2002, 59 (12) : 1147 - 1147
- [9] Lifecycle management of orphan drugs approved in Japan [J]. Orphanet Journal of Rare Diseases, 17